Kazia Therapeutics Ltd
KZIA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001075880
No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Kazia Therapeutics Ltd changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 15 | 18 | +3 |
| Shares | 536.3K | 540.0K | +3.64K (+0.7%) |
| Value | $4.35M | $5.03M | +$684.0K (+15.7%) |
New holders (4)
Institutions that held Kazia Therapeutics Ltd at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Total Clarity Wealth Management, Inc. | 4,755 | $54.0K | 0.03% |
| Wells Fargo & Company | 500 | $6.00K | 0.00% |
| UBS Group AG | 405 | $5.00K | 0.00% |
| Royal Bank of Canada | 54 | $1.00K | 0.00% |
Sold out (1)
Institutions that held Kazia Therapeutics Ltd at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| ACT Capital Management, LLC | 25,000 | $247.0K |